Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROPA-DOP: Dopamine and Furosemide in HFpEF
NCT01901809Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Aug 2013
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dopamine in heart failure with preserved ejection fraction (HFpEF), sponsored by Johns Hopkins University. Started Aug 2013; status: completed.
02
Drugs
dopamine
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT01901809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01901809.